E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 11/3/2005 in the Prospect News Biotech Daily.

Jefferies to review SFBC buy rating

SFBC International Inc.'s buy rating is under review by Jefferies & Co. Inc. analyst David Windley after the company announced third-quarter results. Earnings were $0.52 per share, more than Jefferies' $0.49 estimate, and management was able to reaffirm full year guidance despite expected hurricane-related delays, but margin were down and backlog declined by $39 million, or 10%, over last quarter. Shares of the Miami-based research services company were down $9.98, or 26.34%, at $27.91 on volume of 5,177,734 shares versus the three-month running average of 239,229 shares.


© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.